Wealth Enhancement Advisory Services
UNCY icon

Wealth Enhancement Advisory Services’s Unicycive Therapeutics UNCY Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio UNCY Stock Details UNCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$104K Buy
+19,948
New +$147K ﹤0.01% 3787

Other funds holding UNCY

PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
TFM
TFC Financial Management Boston, Massachusetts $902M AUM 21.74% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return
BWL
Bogart Wealth LLC Mclean, Virginia $2.92B AUM 23.85% 1-Year Est. Return

Wealth Enhancement Advisory Services's UNCY Position: Q2 2026 in Review

Wealth Enhancement Advisory Services opened a new position in Unicycive Therapeutics (UNCY) in Q2 2026: 19,948 shares worth $104K. The stake represents ﹤0.01% of the portfolio and ranks #3787 among its holdings.

6 funds tracked by Wall St. Rank hold UNCY as of Q2 2026.

  • Wealth Enhancement Advisory Services held 19,948 shares of Unicycive Therapeutics worth $104K as of Q2 2026.
  • Unicycive Therapeutics was a new Wealth Enhancement Advisory Services position in Q2 2026.
  • Unicycive Therapeutics made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #3787 holding.
  • 6 funds tracked by Wall St. Rank held Unicycive Therapeutics as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.